Graticule Asia Macro Advisors LLC Aerie Pharmaceuticals Inc Transaction History

Graticule Asia Macro Advisors LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $6.15 Million - $8.09 Million	-109,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $5.24 Million - $7.71 Million	109,500 New	109,500 $7.4 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.